Sign In
Buy MACK
$15.13
+0 (+0%)
At Close: Aug 19, 2024
JFL Capital Ends Campaign at Merrimack
08:45pm, Tuesday, 24'th Sep 2019
Pleased Involvement Catalyzed Much Needed Change at Merrimack and Intends to Continue to Monitor Situation LAKEWAY, Texas , Sept. 24, 2019 /PRNewswire/ -- JFL Capital Management, LLC (together with i
Should You Buy Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) For This Reason?
07:23pm, Thursday, 19'th Sep 2019
As the US$72m market cap Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) released another year of negative earnings...
Merrimack Pharmaceuticals Announces Changes to Board of Directors
01:00pm, Thursday, 19'th Sep 2019
Company Enters into Cooperation Agreement with Newtyn Management and Western Standard
2 Recent 13D Filings On Merrimack Pharma: Western Standard Shows 6.3% Stake, Newtyn Mgmt. Shows 8.8% Stake
12:00am, Thursday, 19'th Sep 2019Merrimack Pharmaceuticals Issues Letter to Shareholders
01:00pm, Monday, 26'th Aug 2019
Company’s Board has Taken Crucial Actions to Maximize Shareholder Value and Preserve More than $500 Million in Potential Future Milestone Payments
JFL Capital Issues Letter to Fellow Merrimack Stockholders
12:30pm, Thursday, 22'nd Aug 2019
Believes Significant Destruction of Value and Lack of Alignment with Stockholders Warrants an Overhaul in the Boardroom Highlights Potential Paths Forward to Unlock Stockholder Value that JFL Capital
JFL Capital Issues Letter Criticizing Board, Appoints New Nominees
12:00am, Thursday, 22'nd Aug 2019Merrimack Pharmaceuticals Reschedules 2019 Annual Meeting of Shareholders for October 17, 2019
01:15pm, Friday, 16'th Aug 2019
Merrimack Pharmaceuticals (MACK) (the “Company” or “Merrimack”) announced today it is rescheduling its 2019 Annual Meeting of Shareholders (the “2019 Annual Meeting”) for October 17, 2019.
Merrimack Pharma To Reschedule 2019 Annual Shareholder Meeting From Oct. 17, 2019 To Sept. 16, 2019
12:00am, Friday, 16'th Aug 2019Merrimack Declares $20 Million Special Dividend
12:30pm, Thursday, 25'th Jul 2019
CAMBRIDGE, Mass., July 25, 2019 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (MACK) today announced that its Board of Directors has authorized and declared a special cash dividend of $20 million o
